ASPR's IBx Portfolio
Description of Project: Cue Health was contracted to ramp-up production of its hand-held diagnostic test for COVID-19.
Unique Impact: The company’s rapid molecular test is based on a nasal swab and a cartridge-based reader and delivers results through a smartphone within about 20 minutes. Cue Health was contracted to provide 30,000 of the reusable, battery-powered instruments by March 2021, while increasing production of its testing kits to 100,000 per day.
Base Award Amount: $480,916,636.62
Category: Testing Capacity and Raw Materials